- Home
- DHR vs MDT Comparison
DHR vs MDT Comparison
Compare DHR & MDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DHR
- MDT
- Stock Information
- Founded
- DHR 1969
- MDT 1949
- Country
- DHR United States
- MDT Ireland
- Employees
- DHR N/A
- MDT N/A
- Industry
- DHR Industrial Machinery/Components
- MDT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- DHR Industrials
- MDT Health Care
- Exchange
- DHR Nasdaq
- MDT Nasdaq
- Market Cap
- DHR 135.4B
- MDT 114.9B
- IPO Year
- DHR N/A
- MDT N/A
- Fundamental
- Price
- DHR $198.94
- MDT $92.84
- Analyst Decision
- DHR Strong Buy
- MDT Buy
- Analyst Count
- DHR 18
- MDT 15
- Target Price
- DHR $260.29
- MDT $102.62
- AVG Volume (30 Days)
- DHR 2.9M
- MDT 7.3M
- Earning Date
- DHR 10-21-2025
- MDT 08-19-2025
- Dividend Yield
- DHR 0.64%
- MDT 3.06%
- EPS Growth
- DHR N/A
- MDT 21.95
- EPS
- DHR 4.71
- MDT 3.62
- Revenue
- DHR $24,013,000,000.00
- MDT $34,200,000,000.00
- Revenue This Year
- DHR $4.47
- MDT $7.58
- Revenue Next Year
- DHR $6.09
- MDT $5.40
- P/E Ratio
- DHR $42.19
- MDT $25.64
- Revenue Growth
- DHR 1.89
- MDT 4.98
- 52 Week Low
- DHR $171.00
- MDT $79.29
- 52 Week High
- DHR $279.90
- MDT $96.25
- Technical
- Relative Strength Index (RSI)
- DHR 42.84
- MDT 54.75
- Support Level
- DHR $202.02
- MDT $91.42
- Resistance Level
- DHR $207.70
- MDT $93.83
- Average True Range (ATR)
- DHR 4.56
- MDT 1.65
- MACD
- DHR -1.28
- MDT -0.04
- Stochastic Oscillator
- DHR 30.90
- MDT 76.95
About DHR Danaher Corporation
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life science and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.
About MDT Medtronic plc.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.